Are you for RU-486? The debate is far from over

  • Ellen Goodman / Boston Globe columnist
  • Monday, October 2, 2000 9:00pm
  • Opinion

BOSTON — Within hours of the announcement, the small line popped up on one of the talk shows that dance across the cable channels: "All Over But the Shouting."

Is that it? Does the FDA approval of RU-486 signal a full victory, a smackdown in the wrestling match over abortion?

RU-486 had been stalled for so long, that I had come to think of it as the flight number of a plane held hostage. And of course it had been held hostage … to politics.

For a dozen years, the political turbulence had kept this drug grounded. Reagan and Bush the Elder had simply banned the drug known medically as mifepristone and popularly as "the abortion pill." But even when the climate changed with Clinton, it took more testing, more trials, more years to find a manufacturer, more time for the FDA to rule.

Now it’s all over? But the shouting?

On television, a shrill spokeswoman for Concerned Women for America warned that women who used RU-486 would be gushing blood and searching for embryo parts all over supermarket floors as they miscarried. In Congress the usual suspects ratcheted up their usual sound bites. J.C. Watts said: "Do-it-yourself abortion has no place in a civilized society."

Meanwhile, those who believe in a woman’s right to choose uttered a collective shout of victory. RU-486 has been touted as more than a medical alternative. It’s the magic drug that would reshape the debate. Tip the balance.

After all, in the past decade, as the pro-life strategy turned from trying to make abortion illegal to trying to make it impossible, many women have had the "right" to abortion without the access. Fewer than 2,000 clinics perform abortions. There are no providers at all in 86 percent of U.S. counties.

The big success of the anti-abortion movement has not been in changing women’s minds. Or even in changing the law. It’s been in frightening off doctors and closing clinics.

At the same time, the public debate shifted disastrously to those rare and troubling late-term abortions. In the past several years, the "shouting" has been over what’s labeled in a graphic and distorted way, "partial-birth abortion."

So many pro-choice advocates have pinned their hopes on mifepristone, though not because "the pill" is a medical panacea. Indeed, it involves two series of drugs and three doctor visits as well as a simulated miscarriage. In France today it accounts for less than half of abortions.

But mifepristone is, as the brand name implies, an "Early Option," used in the first seven weeks when an embryo is no larger than a grain of rice. There is no question that the public feels more comfortable with that early an abortion. So do women.

It also opens up the real possibility of increasing the pool of doctors who may no longer have to risk their lives to practice medicine. A third of doctors who don’t provide abortions now have said they would prescribe and oversee this treatment.

And, more to the point, it can allow women what the Supreme Court says they have: the right to privacy. A woman who can go to her doctor’s office for treatment doesn’t have to pass the gantlet of protestors and placards outside the clinic.

So it’s all over? I’m afraid that the shouting will still drive this debate.

The drug has been approved. But the remaining question about mifepristone is whether and when doctors will feel personally safe enough to prescribe it in their offices. Will they feel comfortable in states that still require a report on every abortion? Or in North Dakota, which requites that the remains be cremated or buried or incinerated.

What kind of chilling effect will the existing laws have on doctors and women in their homes and offices? What kind of chilling effect do "shouters" have on legislators and doctors?

The anti-abortion forces have fought RU-486 because they know it’s harder to target 20,000 doctors than 2,000 clinics. It’s much harder to intimidate and humiliate those patients.

But mifepristone doesn’t make the need for clinics moot. Nor does it mute the political reality that we are a Justice or two short of overturning abortion rights.

So here we are. In only four weeks, just a few days before the election, mifepristone will finally be available in America. It’s not all over. But in the midst of the shouting, may I add one cautious cheer: "It’s about time."

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

Rivian, based in Irvine, Calif., has introduced its new R2 models, smaller and more affordable SUVs. (Rivian)
Editorial: Open electric vehicle market to direct sales

Legislation would allow EV makers to sell directly to customers, making lease or purchase easier.

toon
Editorial cartoons for Sunday, Feb. 16

A sketchy look at the news of the day.… Continue reading

President Donald Trump listens alongside Elon Musk as he explains the administration’s cost-cutting efforts in the Oval Office of the White House in Washington, on Tuesday, Feb. 11, 2025. Musk has for weeks posted on social media about government spending, often amplifying and seeding false information. (Eric Lee/The New York Times)
Comment: This crisis can’t be left to courts alone

The courts can uphold the law, but they can’t match the speed of the executive branch in tearing down systems.

Eco-nomics: Climate change is making insurance a risky bet

Keeping home insurance affordable amid climate change will take adaptation to threats and broader efforts.

The Buzz: When you gotta boogie, best to shake it off, kid

A pasquidadian review of the week’s news.

Stick with solutions to homelessness that have heart

A friend of mine, a poet from Leningrad who was born during… Continue reading

SAVE Act would restrict voting rights

As a mother, I am flabbergasted by the continued and increasing attacks… Continue reading

People walk adjacent to the border with Canada at the Peace Arch in Peace Arch Historical State Park, where cars behind wait to enter Canada at the border crossing Monday, Aug. 9, 2021, in Blaine, Wash. Canada lifted its prohibition on Americans crossing the border to shop, vacation or visit, but America kept similar restrictions in place, part of a bumpy return to normalcy from coronavirus travel bans. (AP Photo/Elaine Thompson)
Editorial: U.S. and Canada better neighbors than housemates

President Trump may be serious about annexing Canada, but it’s a deal fraught with complexities for all.

CNA Nina Prigodich, right, goes through restorative exercises with long term care patient Betty Long, 86, at Nightingale's View Ridge Care Center on Friday, Feb. 10, 2023 in Everett, Washington. (Olivia Vanni / The Herald)
Editorial: Boost state Medicaid funding for long-term care

With more in need of skilled nursing and assisted-living services, funding must keep up to retain staff.

bar graph, pie chart and diagrams isolated on white, 3d illustration
Editorial: Don’t let state’s budget numbers intimidate you

With budget discussions starting soon, a new website explains the basics of state’s budget crisis.

Solar for All program is very beneficial and should be kept

The recent Herald article about the $156 million grant for Solar for… Continue reading

Comment: Keeping health care fair, affordable as costs rise

Bills in the state Senate would look to control costs and keep decisions in the hands of providers.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.